This website uses cookies to improve user experience. By continuing to use this website, you consent to our use of these cookies. To learn more about how we use and manage cookies, see our Privacy Policy and Cookie Policy.
Whether dosed every 7 or 14 days in pivotal trials
Dosing schedules that fit your lifestyle
High and sustained steady-state FIX levels
*Hemophilia FIX Market Assessment. Third-Party Market Research.
†Zero median annualized spontaneous bleeding rate when dosed at 7 or 14 days in clinical trials.
‡Once well controlled (1 month without spontaneous bleeding or requiring dose adjustments on a weekly dose of ≤40 IU/kg), people 12 years and older can be transitioned to 14-day dosing.
§The average dose for people receiving prophylaxis every 7 days was 37 IU/kg.
Connect and learn more about living with and managing hemophilia B
“IDELVION extended dosing means I’ll have more time to study and hang out with friends at college.”
IDELVION offers a wide variety of resources
to help people with hemophilia B.
